4//SEC Filing
CLAUSEN PETER 4
Accession 0001437749-22-015095
CIK 0001091596other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 6:18 PM ET
Size
5.8 KB
Accession
0001437749-22-015095
Insider Transaction Report
Form 4
CLAUSEN PETER
CSO/COO
Transactions
- Award
Option to Purchase Common Stock
2022-06-06+275,000→ 275,000 totalExercise: $0.75From: 2022-03-04Exp: 2032-03-04→ Common Stock (275,000 underlying)
Footnotes (2)
- [F1]The grant of these options was approved by the issuer's Board of Directors on March 4, 2022, subject to stockholder approval of an amendment to increase the number of shares available for issuance under the issuer's 2016 Omnibus Incentive Compensation Plan pursuant to which the options were granted. Stockholder approval was obtained by means of a written consent and the issuer filed a related Information Statement on Schedule 14C with the SEC on April 27, 2022. The stockholder approval became effective on June 6, 2022.
- [F2]One-third exercisable immediately on 03/04/2022 and the remainder exercisable quarterly over three years.
Documents
Issuer
Nuo Therapeutics, Inc.
CIK 0001091596
Entity typeother
Related Parties
1- filerCIK 0001605411
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 6:18 PM ET
- Size
- 5.8 KB